Patent · US Expired

Endothelin antagonists

US6162927A · kind A · utility

15Cited by
6References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 4, 1997
Grant dateDec 19, 2000
Priority date
Expiry dateAug 4, 2017

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/59
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound of the formula (I): ##STR1## or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.